ELAVL4 and amyotrophic lateral sclerosis: Using label-free mass spectrometry, we identified 88 candidate proteins enriched in the insoluble fraction of ALS patient-derived iPSC-MN, among the RBPs NOVA1, NOVA2, ELAVL4, RBFOX2 and RBFOX3.